Cellular and nuclear uptake of [
Introduction
Thyroid hormone induces an increase in cardiac contractility and frequency, resulting in a greater cardiac output (Polikar et al. 1993 , Toft & Boon 2000 , Klein & Ojamaa 2001 , and a proportional change in energy turnover (Clausen et al. 1991) . Thyroid hormone also induces relaxation of vascular smooth muscle (Ojamaa et al. 1996) , and it is very effective in reducing serum cholesterol (Staels et al. 1990) . Recently, the concept has been discussed that initiation of thyroxine (T 4 ) replacement therapy may precipitate angina pectoris (Gammage & Franklyn 1997) , whereas increased serum triiodothyronine (T 3 ) at the time of admission to hospital is associated with a greater risk for the development of myocardial ischemia (Peters et al. 2000) . This underscores the importance of developing thyromimetic compounds with lipid-decreasing activity, without cardiovascular and thermogenic effects (Boyd & Oliver 1960 , Underwood et al. 1986 , Stephan et al. 1996 , Ichikawa et al. 2000 , Trost et al. 2000 .
Patients undergoing coronary bypass surgery (Holland et al. 1991 , Klemperer et al. 1995 and patients with congestive heart failure (Hamilton 1993 , Hamilton & Stevenson 1996 may show typical changes in serum thyroid hormone parameters -low serum T 3 , high serum reverse T 3 and normal T 4 and thyrotropin (TSH) concentrations -known as the euthyroid sick syndrome (Docter et al. 1993 ). Whether or not this condition should be treated remains a matter of debate (Klemperer et al. 1995 , Utiger 1995 , Camacho & Dwarkanathan 1999 . However, during the past 5-10 years, clinical studies have explored the possibility of improving heart function using treatment with T 3 or T 4 (Moruzzi et al. 1996 , Chowdhury et al. 1999 , Mullis-Jansson et al. 1999 , both in children with congenital heart disease and in elderly patients with congestive heart failure. To date, the thyroid hormone analog, diiodothyropropionic acid (DITPA), which possibly has a greater effect on cardiac contractility than on frequency, has been applied in animal studies (Pennock et al. 1993 , Morkin et al. 1996 , Spooner et al. 1999 .
With the purpose of suppressing thyrotropin (TSH) secretion in patients with thyroid cancer (Pujol et al. 2000) , triiodothyroacetic acid (Triac) has been tested for specificity at the pituitary and the peripheral level (Beck-Peccoz et al. 1988 , Sherman & Ladenson 1992 , Everts et al. 1994 , Sherman et al. 1997 . In addition, tetraiodothyroacetic acid (Tetrac) was more potent than T 4 in reducing TSH release in isolated pituitary cells (Everts et al. 1995) and in hypothyroid rats (Lameloise et al. 2001) , but it was less efficient in inducing cardiac hypertrophy (Lameloise et al. 2001) . Recent work on mitochondria indicates that T 3 metabolites such as 3,5-diiodothyronine (3,5-T 2 ) may have thermogenic effects (Goglia et al. 1999) . Finally, several studies have demonstrated acute effects of T 3 (Davis & Davis 1993 ) and 3,5-T 2 (Huang et al. 1999) on the heart, in particular on ion channels.
In view of the significance of plasma membrane transport for the bioavailability of thyroid hormones (Hennemann et al. 1998 , and the possible existence of different transport systems in different tissues (Kragie 1994 , Everts et al. 1996a , we have previously explored the thyroid hormone transport system in the heart (Everts et al. 1996b , Van der Putten et al. 2001 , Verhoeven et al. 2001 . In the present study we continued this work by comparing the uptake of [ 
Materials and Methods

Animals
All experiments were performed using 2-3-day-old Wistar rats of both sexes, obtained from laboratory stock. Rats were killed by decapitation, and hearts were quickly dissected and processed as described below, to isolate cardiomyocytes.
Cell culture
Primary cultures of neonatal rat cardiomyocytes were prepared as described in detail previously (Blondel et al. 1971) , with some modifications (Van Heugten et al.1994 , Everts et al. 1996b , Verhoeven et al. 2001 . In brief, hearts were cut for 1 min and dissociated with 0·1% trypsin for 10 min at 33 C. Cells from the first treatment with trypsin were decanted and discarded, and the remaining tissue was further digested with fresh enzyme and decanted. DMEM with medium 199 (M199) (4:1), 5% FCS, 5% horse serum and 2% penicillin/streptomycin was then added to the suspended cells. This procedure was repeated seven times until all tissue was dissociated. Deoxyribonuclease (20 U/ml) was added, and the remaining tissue from the last step, together with the trypsinized cells, was centrifuged (100 g) for 5 min. The supernatant was discarded, and the cells were resuspended in 30 ml DMEM-M199 with 5% FCS, 5% horse serum, and 2% penicillin/streptomycin. The cell suspension was passed through nylon mesh, and the dispersed cells were preplated (Blondel et al. 1971 ) into 250 ml culture flasks for 60 min (37 C, 5% CO 2 ) to remove fibroblasts. After this procedure, the preparation consists of more than 90% cardiomyocytes (Van Heugten et al. 1994) . Cells of the enriched cardiomyocyte fraction were plated into 48-well culture dishes at subconfluent density (5 10 5 cells/well) in 1-ml volumes of DMEM-M199 with 5% FCS-5% horse serum-2% penicillin/streptomycin, and in some cases at a density of 10 6 cells/well in 2-ml volumes in 24-well culture dishes.
The cells were incubated in a humidified 5% CO 2 atmosphere at 37 C for 1 day. After 1 day, the cells revealed spontaneous and synchronous beating, and the medium was replaced by the original culture medium. Experiments were routinely performed after 5 days. In a series of experiments, the cultured cells were exposed to 10 nM T 3 or DITPA from the start of culture.
Although culturing cardiomyocytes in the presence of serum may result in proliferation of contaminating fibroblasts that also show thyroid hormone transport (Docter et al. 1987) , we have previously shown that uptake of thyroid hormones is comparable in cardiomyocytes cultured for 5 days in absence or presence of serum (Everts et al. 1996b , Verhoeven et al. 2001 (Everts et al. 1994 (Everts et al. , 1996b . Cells were preincubated (0·5 ml) for 30 min and incubated (0·25 ml) for from 15 min to 24 h at 37 C without or with 10 µM unlabeled T 3 , Triac, Tetrac, 3,3 -T 2 , 3,5-T 2 , or 1 nM-10 µM DITPA, T 3 , T 4 or Triac, and in all cases After incubation, the medium was removed and the cells were washed with 1 ml ice-cold saline to remove tracer not bound to the cells. This washing procedure proved to be sufficient (Verhoeven et al. 2001) . Cells were dissolved in 1 ml 0·1 M NaOH and counted for iodine-125 activity in a 16-channel gamma-counter (NE 1600, Nuclear Enterprises, Edinburgh, UK). The amount of The same procedure was applied to incubations without cells (blanks). All results were corrected for the amount of radioactivity recovered from the wells without cells.
Nuclear [ 125 I]T 3 and [ 125 I]Triac binding
Cells were cultured at a density of 10 6 cells/well in 24-well culture dishes as described above. Preincubation (30 min) and incubation (2 h) were performed at 37 C in a volume of 0·5 ml, and [
125 I]T 3 (200 000 c.p.m.; 100 pM) or [ 125 I]Triac (500 000 c.p.m.; 300 pM) during incubation. Unlabeled T 3 or Triac (both 10 µM) were present only during incubation. After incubation, cells were washed once with 2 ml ice-cold saline. The cells were scraped from the wells with a rubber policeman in 1 ml PBS (on ice) and the wells were washed with 0·5 ml PBS. These two aliquots were combined and centrifuged (300 g at 4 C for 7 min) and the cell pellet counted (30 s) and solubilized in 1 ml PBS containing 0·5% Triton X-100 (Everts et al. 1996b , Verhoeven et al. 2001 . After 2 min of continuous vortexing, nuclei were spun down (900 g at 4 C for 5 min) and washed once with 1 ml PBS containing 0·5% Triton X-100. The nuclear pellets were counted for 5 min and frozen for determination of DNA.
Free hormone concentrations
Calculation of the free hormone concentration was based on determination of the free fraction by equilibrium dialysis (Sterling & Brenner 1966) . As shown previously (Everts et al. 1994) , the free fractions of T 3 and Triac in medium with 0·5% BSA were 3·45 0·19% (n=8) and 0·41 0·03% (n=5) respectively -a ninefold difference. In the present study, the free T 3 fraction was not changed by the addition of 10 µM unlabeled T 3 , 3,3 -T 2 , 3,5-T 2 , Triac or Tetrac, and only slightly by 10 µM T 4 (4·21%; n=2). Upon addition of 0, 1 nM, 10 nM, 100 nM, 1 µM or 10 µM DITPA, the free T 3 fraction also showed a slight increase: from 3·22 0·08% (n=5) to 3·61% (n=2), 3·49% (n=2), 3·45% (n=2), 3·78% (n=2) and 4·36 0·06% (n=3) respectively. The free Triac fraction was 0·38 0·02% (n=6), and did not change with 10 µM unlabeled Triac.
DNA and protein determinations
DNA content was determined using a fluorimetric method (Downs & Wilfinger 1983) . The cellular protein content was determined with the Bio-Rad Protein Assay-Kit (Bio-Rad, Munich, Germany). Cells plated at a density of 5 10 5 cells/well contained about 0·1 mg protein/well after 5 days of culture.
Chemicals and isotopes
All reagents used for cell isolation and cell culture were obtained from Gibco Europe (Breda, The Netherlands), with the exception of trypsin and deoxyribonuclease (Boehringer, Mannheim, Germany I]Triac (2730 µCi/µg) was prepared from Na 125 I and 3,5-Diac using the chloramine-T method (Rutgers et al. 1989) . Sephadex LH-20 was from Pharmacia (Uppsala, Sweden). All other reagents were of the highest purity available.
Calculations and statistics
On the basis of the free hormone fractions in the incubation buffer with 0·5% BSA, the chemical concentration of T 3 (100 pM) or Triac (240 pM) in the buffer, and the incubation volume, the counts per minute (percentage added dose) were converted to fmol/pM free hormone. In case the free hormone fraction was unknown -for example in the cellular pellet and the nuclei (Table 1) (Fig. 1A) and as fmol/pM free hormone (Fig. 1B) . Both uptakes showed a steep phase up to 1 h of incubation. Between 1 and 4 h of incubation, [
125 I]Triac uptake reached equilibrium, whereas [
125 I]T 3 uptake showed a further increase. As can be seen in Fig. 1A Effect of DITPA T 3 uptake was also measured over a 4-h incubation period in the absence or presence of 10 µM DITPA (Fig. 2) . Results are expressed as fmol/pM free T 3 . At incubation times 15 min, 1 h and 4 h, the presence of 10 µM DITPA reduced [
125 I]T 3 uptake by 28%, 45% and 56% (all n=6; P<0·05) respectively.
Plasma membrane transport of [ 125 ]T 3
Effects of T 3 , T 4 , Triac, DITPA, Tetrac 3,3 -T 2 , and 3,5-T 2 Figure 3 shows the competitive effects of increasing concentrations of unlabeled T 3 , T 4 , Triac and Data show mean S.E. of triplicate observations from two experiments. Cardiomyocytes were prepared from 2-day-old rats, and cultured for 1 day in 24-well dishes in DMEM-M199-5% FCS-5% horse serum at a density of about 10 6 cells/well. After 1 day, the culture medium was changed and culture was continued for 4 days. Cells were incubated at 37 C for 2 h with 
DITPA on the 15-min uptake of [
125 I]T 3 , expressed as fmol/pM free T 3 . T 3 itself resulted in a clear dosedependent inhibition, and the maximum effect was seen with 10 µM (45%; P<0·01) (Fig. 3A) . T 4 showed a dose-dependent inhibition, but the maximum effect at 10 µM (27%) was not significant (Fig. 3B ). Exposure to Triac did not result in reduction of [ 125 I]T 3 uptake (Fig. 3C) , whereas DITPA showed a stepwise reduction with increasing concentrations (Fig. 3D ), but the maximum effect was now 20% (NS), as compared with 28% in Fig. 2 .
The effects of a number of metabolites tested at a concentration of 10 µM on [ 125 I]T 3 uptake at 15 min, 1 h, 4 h and 24 h was 0·089 0·017 (n=9), 0·222 0·017 (n=9), 0·433 0·038 (n=9) and 0·352 0·038 (n=9) fmol/pM free T 3 respectively. After 15 min, [ 125 I]T 3 uptake was inhibited by 52% (n=9; P<0·001) in the presence of 10 µM 3,3 -T 2 , and by 17% (n=9; NS) in the presence of 10 µM 3,5-T 2 , whereas 10 µM Triac or Tetrac had no effect at all (both n=9; NS). After 24 h of incubation, the relative effect of 3,3 -T 2 was less (26%, n=9; P<0·02) than that observed after 15 min of incubation, whereas the effects of 3,5-T 2 (13%), Triac and Tetrac (both 19%) were still not significant. The effects of 10 µM unlabeled T 3 are given for comparison, and amounted to 52% (P<0·001) and 63% (P<0·001) after 15 min and 24 h respectively.
Presence of DITPA and T 3 during culture
A second approach to evaluate possible effects of DITPA on the T 3 uptake system was to add 10 nM DITPA during culture for 5 days and compare its effect with the presence of 10 nM T 3 . This experiment was performed twice and, after culture, the time course of [ 125 I]T 3 uptake was tested for from 15 min to 24 h in the absence or presence of 10 µM unlabeled T 3 (Fig. 5) . The time-course of [ 125 I]T 3 uptake in the presence of 10 µM unlabeled T 3 was about the same in the three culture conditions (compare Fig. 5A , B and C, lower curves). However, uptake of [ 125 I]T 3 without additions during incubation was significantly greater in cells that had been cultured under control conditions (Fig. 5A ) than in cells that had been cultured in the presence of 10 nM T 3 (Fig. 5B) or DITPA (Fig. 5C ). Whereas the absolute reduction in T 3 uptake by 10 µM unlabeled T 3 after 24 h of incubation was 2·01% of the dose (42% inhibition; P<0·001) in the cells cultured under control conditions, this was only 0·44% and 0·47% of the dose (12% inhibition; NS) in cells cultured in the presence of 10 nM T 3 or DITPA. The protein content per well under the different culture conditions was the same.
Discussion
In the present study, we explored further the uptake mechanism for T 3 in heart by comparing uptake of ]Triac and by testing the effects of thyroid hormone metabolites and the analog DITPA on T 3 uptake in neonatal rat cardiomyocytes. Our previous studies showed that T 3 uptake in neonatal heart occurred by a temperature-and energy-dependent mechanism that was slightly dependent on the Na + gradient (Everts et al. 1996b , Van der Putten et al. 2001 , and sensitive to Ca 2+ blockers (Verhoeven et al. 2001) , whereas results for T 4 uptake were less clear. The effects of the Ca 2+ channel inhibitors were not secondary to inhibition of Ca 2+ influx, suggesting interference with the putative T 3 carrier in the plasma membrane, rather than an energetic linkage to effects of T 3 on ion channels (Verhoeven et al. 2001) .
Comparison of the time-courses of T 3 and Triac uptake in neonatal rat cardiomyocytes showed that, when expressed as fmol/pM free hormone, Triac uptake was about 30% greater than that of T 3 , but the difference was not as large as in cultured pituitary cells, in which an almost twofold difference was found (Everts et al. 1994) . When the 2-h cellular uptakes of T 3 and Triac were measured and expressed as percentages of the doses, a fivefold greater value for T 3 was observed, whereas the relative inhibition by 10 µM of the respective unlabeled hormone was roughly the same. Together, these findings indicate that Triac is taken up by cardiomyocytes and bound to their nuclear receptors, as in pituitary cells (Everts et al. 1994) . In contrast to pituitary cells, in which T 3 uptake was inhibited by Triac and vice versa (Everts et al. 1994) , the 15-min T 3 uptake in cardiomyocytes was not significantly inhibited by increasing concentrations of Triac. As T 3 and T 4 are scarcely metabolized by deiodination or conjugation in neonatal cultured cardiomyocytes within 24 h (Everts et al. 1996b) , we extended the incubation periods to test the various analogs up to 24 h. However, even after 24 h of incubation, we could not detect any inhibitory effect of 10 µM Triac, suggesting different transport mechanisms for T 3 and Triac in heart. Addition of Triac to the diet of rats induced an increase in oxygen consumption and heart rate, roughly to the same extent as addition of D-T 3 (Boyd & Oliver 1960) . In contrast, neither Triac nor D-T 3 acutely stimulated Na + currents in cardiomyocytes (Huang et al. 1999) . Tetrac 10 µM reduced neither the plasma membrane uptake of T 3 at 15 min, or its cellular uptake after 24 h. This is clearly at variance with the findings in pituitary cells, in which Triac and Tetrac inhibited [
125 I]T 3 uptake over the range 15 min-4 h to the same extent as unlabeled T 3 , and both suppressed thyrotropin releasing hormone (TRH)-stimulated TSH release (Everts et al. 1994 (Everts et al. , 1995 . Tetrac has also been reported to be more effective than T 4 in suppressing TSH secretion in vivo in hypothyroid rats (Lameloise et al. 2001) , whereas it was less effective in inducing cardiac hypertrophy. In our study, the inhibitory effect of T 4 (around 25%) on T 3 uptake was, if anything, greater than that of Tetrac, albeit not significantly so.
Of the two other metabolites tested, 3,3 -T 2 significantly reduced T 3 uptake in cardiomyocytes, the effect after 15 min (52% inhibition) being twice as large as that after 24 h (26% inhibition), suggesting that 3,3 -T 2 primarily interacted at the level of the plasma membrane. The other diiodothyronine, 3,5-T 2 , had no effect on T 3 uptake in heart cells between 15 min and 24 h of incubation. Interestingly, 3,5-T 2 has been shown to be more effective than 3,3 -T 2 in suppressing TRH-induced TSH release in pituitary cells (Everts et al. 1995) . It is also regarded as the important diiodothyronine with respect to (direct) stimulation of heat production in mitochondria (Goglia et al. 1999) , and is just as effective as T 3 in acutely stimulating Na + currents in neonatal rat cardiomyocytes (Huang et al. 1999) .
Because of its possible preferential effect on myocardial contractility, the analog DITPA has been used, with the purpose of improving heart function after infarction, but so far only in animal studies (Pennock et al. 1993 , Morkin et al. 1996 , Spooner et al. 1999 . It has been shown that DITPA binds to bacterially expressed thyroid hormone receptors (Morkin et al. 1996) . At the cellular level, DITPA induces sarcoplasmic reticulum Ca 2+ transport and protein expression (Pennock et al. 2000) , but interpretation of data on changes in myosin heavy-chain isoenzyme has been more complicated (Spooner et al. 1999) . From this point of view, there remains a lack of understanding of how DITPA works (Spooner et al. 1999) . In the present study, DITPA was tested for effects on T 3 uptake in cardiomyocytes. Up to a concentration of 10 µM, DITPA had a less clear effect on the 15-min T 3 uptake (20-28%) as compared with 10 µM T 3 itself (46-52%). In contrast, the effect of 10 µM DITPA after 4 h of incubation was at least as great (56%) as that of unlabeled T 3 (42-63%; compare Figs 2 and 5A), suggesting that DITPA can bind to the cytosolic or nuclear T 3 binding sites of the cardiomyocytes. When DITPA was added during culture at a concentration of 10 nM, its effect was comparable to that of the same concentration of T 3 : the inhibitory effect of 10 µM T 3 on cellular T 3 uptake at 24 h was only 12%, whereas it was 42% in cells cultured under control conditions. As we have not tested whether DITPA interacts with the nuclear T 3 receptors, it is difficult to conclude whether DITPA primarily interferes with plasma membrane T 3 transport or with cytosolic or nuclear T 3 binding. To what extent the inhibitory effect of DITPA on T 3 uptake in the cardiomyocyte results in attenuation or stimulation of thyromimetic effects, for example on expression of the Na + ,K + -ATPase isoforms, is currently being investigated.
The aromatic amino acid, tyrosine, the precursor of iodothyronines, and tryptophan share the same transport system (Christensen 1990) . In two studies with cardiomyocytes, we reported that tryptophan in concentrations of 0·5 and 2 mM significantly reduced T 3 uptake (maximum response 30-45%; Everts et al. 1996b , Van der Putten et al. 2001 . Moreover, the effects of tryptophan were additive to those of oligomycin, an inhibitor of oxidative phosphorylation, suggesting that at least two different transport systems may be responsible for T 3 uptake in neonatal heart (Van der Putten et al. 2001) . One could be a transport system that is capable of transporting aromatic amino acids. Kragie (1994) and Hennemann et al. (2001) have reviewed the properties of thyroid hormone transport mechanisms in many cell types. We have previously compared uptake mechanisms for thyroid hormones in pituitary and liver, and postulated that regulation of the transport in these two tissues was different (Everts et al. 1996a) . This difference could play a part in maintenance of the low serum T 3 and normal TSH concentrations in non-thyroidal illness and fasting (Everts et al. 1996a , Hennemann et al. 1998 . When the present data are compared with the results obtained in pituitary cells (Everts et al. 1994 (Everts et al. , 1995 , it seems that the transport mechanism for T 3 into the heart is different. Whether T 3 uptake in heart is similar or different as compared with that in liver (Everts et al. 1996a) remains to be established. This question is of relevance to the development of drugs with tissue-selective thyromimetic activity (Ichikawa et al. 2000 , Trost et al. 2000 .
Conclusion
3,3 -T 2 , and to a lesser extent DITPA and T 4 , inhibit plasma membrane T 3 uptake in the cardiomyocyte, whereas 3,5-T 2 , Triac and Tetrac have no significant effects. In contrast, Triac itself is taken up by the cardiomyocyte, but probably through a transport mechanism other than that for T 3 . Our current research plan includes investigation of whether exposure of cardiomyocytes to Triac and DITPA results in thyromimetic effects, and whether exposure to compounds that inhibit T 3 transport (in particular 3,3 -T 2 ) results in reduction of T 3 -induced effects in the cardiomyocyte.
